Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2010
11/04/2010WO2010126914A1 Pyridinone antagonists of alpha-4 integrins
11/04/2010WO2010126553A1 Compositions and methods for reducing the likelihood of implantation failure or spontaneous abortion in recipients of assisted reproduction
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126102A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125762A1 Antibody-type rejection-preventing agent
11/04/2010WO2010125544A1 Immunogenic nanomedicine composition and preparation and uses thereof
11/04/2010WO2010125082A1 Oxazole substituted indazoles as pi3-kinase inhibitors
11/04/2010WO2010124997A1 A nutritional composition comprising an apple extract and reducing food allergy symptoms, especially in children
11/04/2010WO2010124826A1 Substituted imidazoquinoxalines
11/04/2010WO2010124377A1 Mutants of francisella tularensis and uses thereof
11/04/2010WO2010124361A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
11/04/2010WO2010080188A3 Epitope targeted anthrax vaccine
11/04/2010WO2010075558A3 Compositions and methods for inhibition of the jak pathway
11/04/2010WO2010017403A9 Therapeutic compositions, devices and methods for observing treated tissues
11/04/2010WO2009141142A8 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280130 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
11/04/2010US20100280125 Medicinal agent
11/04/2010US20100280106 Oral composition to reduce cold symptoms and duration of same
11/04/2010US20100280102 Double-stranded ribonucleic acid with increased effectiveness in an organism
11/04/2010US20100280086 Substituted thiophenes
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280052 Use of antivirals to treat cmv-related conditions
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280045 Novel compounds
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280029 Novel compounds
11/04/2010US20100280028 Cxcr3 receptor antagonists
11/04/2010US20100280027 Pharmaceutical compounds
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100279994 Ansamycin Formulations and Methods of Use Thereof
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279327 Method of treating diseases with parp inhibitors
11/04/2010US20100278945 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
11/04/2010US20100278941 Enhanced erythropoiesis and iron metabolism
11/04/2010US20100278915 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010US20100278904 Nucleotide vaccine
11/04/2010US20100278903 Prophylactic and immunomodulatory compositions and uses
11/04/2010US20100278875 Prostaglandin e2 (pge2) as an adjuvant in monoclonal antibody generation
11/04/2010US20100278870 Adenoviral vector-based malaria vaccines
11/04/2010US20100278866 Borrelia diagnostics and screening methods
11/04/2010US20100278863 Reoviruses
11/04/2010US20100278858 Process for preparing attenuated viral strains
11/04/2010US20100278856 BoNT/A PEPTIDES AND METHODSOF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY
11/04/2010US20100278854 Chlamydia antigens
11/04/2010US20100278847 Mutually suppressive gene/inhibitor combinations for non-antibiotic selection of recombinant strains
11/04/2010US20100278846 Nasal-administered vaccines using multi-screened nalt-targeting and phagocytic polypeptide transport sequences
11/04/2010US20100278841 DOWN-REGULATION OF MORTALIN BY siRNA
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods
11/04/2010US20100278819 Streptococcus pneumoniae vaccines
11/04/2010US20100278816 B7-dc binding antibody
11/04/2010US20100278812 Nasal immunization
11/04/2010US20100278808 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
11/04/2010US20100278799 Composition for Improving Nutritional Status, Reducing Frequency of Fever and/or Increasing Immunocompetence of the Elderly
11/04/2010US20100278795 Lactic acid bacterium-containing preparation
11/04/2010US20100278783 Method of Preparing Autologous Cells and Method of Use for Therapy
11/04/2010US20100278781 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
11/04/2010US20100278776 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
11/04/2010US20100278774 Fusion molecules and il-15 variants
11/04/2010US20100278759 Topical Therapeutic Delivery System
11/04/2010US20100278727 Alpha-Emitting constructs and uses thereof
11/04/2010US20100278725 Methods and devices for lymphatic targeting
11/04/2010DE102009017966A1 Healthy liquid food/food supplement, useful e.g. in a dried plant extract, which is useful to prepare an infusion drink, comprises a sliced nettle leaf, sliced horsetail, speedwell herb and honey, in an aqueous solution
11/04/2010CA2760305A1 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
11/04/2010CA2760151A1 Pyridinone antagonists of alpha-4 integrins
11/04/2010CA2760098A1 Mutants of francisella tularensis and uses thereof
11/04/2010CA2760096A1 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
11/04/2010CA2760077A1 Substituted imidazoquinoxalines
11/04/2010CA2759476A1 Novel compounds
11/04/2010CA2759400A1 Chimeric factor h binding proteins (fhbp) and methods of use
11/04/2010CA2757511A1 A nutritional composition comprising an apple extract and reducing food allergy symptoms, especially in children
11/03/2010EP2246346A1 Indolylmaleimide derivatives as protein kinase inhibitors
11/03/2010EP2246067A2 Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes
11/03/2010EP2246064A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof
11/03/2010EP2245067A2 Methods of using cadherin 11 (cdh11) antagonists
11/03/2010EP2245022A2 Antagonists of prostaglandin d2 receptors
11/03/2010EP2245012A1 Inhibitors of p38 map kinase
11/03/2010EP2244734A2 A method of inducing tolerance to an allergen
11/03/2010EP2244731A2 Canine influenza vaccines
11/03/2010EP1970372B1 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1242437B1 Novel stromelysin inhibitors
11/03/2010EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection
11/03/2010CN1973850B Medicine composition for treating allergic rhinitis and its preparation process
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN1872137B Drop pills of total glycoside of Jiaogulan, and preparation method
11/03/2010CN1551783B Use of analog K121 antibody in preparing medicine for K type multiple myeloma
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 1172